| |
|
|
|
iBio Inc.  
|
|
2.1602 -0.12 (-0.05%) |
07-10 09:42 |
|
Open: |
2.25 |
Pre close: |
2.28 |
Target:
|
3.15
|
|
High: |
2.19 |
Low: |
2.12 |
Resistance:
|
2.70
3.15
|
|
Volume: |
1,211,618 |
Market Cap: |
259M |
Support:
|
1.88
1.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.16
 |
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
1.82 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
1.34 |
Stochastic Oscillator |
%K(14,3):
|
67.69 |
|
MA(250): |
0.79 |
%D(3): |
60.01 |
|
Average Volume(K) |
3-Month: |
1563695
|
52-Week |
High:
|
3.40 |
|
10-Days: |
3271241 |
Low: |
0.05 |
|
RSI |
RSI(14):
|
64.88  |
Change(%): |
221.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.975 |
Return on Equity (ttm) |
-320.6 |
Shares Out. (M) |
119.80 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-24.0 |
Shares Float (M) |
101.80 |
|
EPS Est. Next Year |
-0.200 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.78 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-81.8 |
% Held by Institutions |
11.56 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.017 |
Shares Short (K) |
2140 |
|
Book Value (p.s.) |
0.040 |
EBITDA (p.s.) |
-0.107 |
P/E |
-2.34 |
|
Sales Per Share |
0.011 |
Qtrly Earnings Growth |
0.00 |
P/BV |
57.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.87 |
P/S |
208.51 |
|
Operating Margin |
-1138.46 |
Levered Free Cash Flow
(M) |
-7.82 |
P/CF |
-19.69 |
|
|
|
|
|
|
